[HTML][HTML] Severe COVID-19 ARDS treated by bronchoalveolar lavage with diluted exogenous pulmonary surfactant as salvage therapy: In pursuit of the holy grail?
B Ruaro, P Confalonieri, R Pozzan, S Tavano… - Journal of Clinical …, 2022 - mdpi.com
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan… - Journal of clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
[HTML][HTML] Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan… - Journal of Clinical …, 2022 - ncbi.nlm.nih.gov
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan… - Journal of Clinical …, 2022 - search.ebscohost.com
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan… - Journal of Clinical …, 2022 - search.proquest.com
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan… - Journal of Clinical …, 2022 - europepmc.org
Background Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan, S Tavano… - 2022 - pesquisa.bvsalud.org
BACKGROUND: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
Severe COVID‐19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
B Ruaro, P Confalonieri, R Pozzan, S Tavano… - JOURNAL OF …, 2022 - arts.units.it
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID‐19) is char‐
acterized by inflammatory lung injury, progressive parenchymal stiffening and consolidation …
acterized by inflammatory lung injury, progressive parenchymal stiffening and consolidation …
[PDF][PDF] Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail
B Ruaro, P Confalonieri, R Pozzan, S Tavano… - J. Clin. Med, 2022 - researchgate.net
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
[PDF][PDF] Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail
B Ruaro, P Confalonieri, R Pozzan, S Tavano… - J. Clin. Med, 2022 - arts.units.it
Background: Severe pneumonia caused by coronavirus disease 2019 (COVID-19) is
characterized by inflammatory lung injury, progressive parenchymal stiffening and …
characterized by inflammatory lung injury, progressive parenchymal stiffening and …